Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | IMNM Immunome, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $23.93 -0.1% | $15.37 -3.9% |
| StockIQ Score | 40D Weak Risk: Medium | 35F Weak Risk: High |
| Technical | 29F | 13F |
| Fundamental | 30F | 35F |
| Growth | 54C- | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 42D | 50C- |
| Risk | 48D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Immunome (IMNM) scores higher than Ascentage Pharma (AAPG) on the investor (40 vs 35), technical (29 vs 13) and growth (54 vs 50) metrics, and both share the same valuation score of 38. AAPG leads on the fundamental score (35 vs 30).